L'intérêt à découvert pour Singular Genomics Sys donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Singular Genomics Sys. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Singular Genomics Sys (NASDAQ:OMIC) Stock, Rapport sur les intérêts à découvert

Singular Genomics Sys

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

Singular Genomics Systems, Inc. - Common Stock

Singular Genomics Systems Inc

Susquehanna analyst James Friedman maintains Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) with a Positive and raises the price target from $88 to $103.

News

Price Target

Analyst Ratings

Susquehanna Maintains Positive on Fidelity National Info, Raises Price Target to $103

The Company is updating previous financial guidance for fiscal year 2024 as follows:
<ul>
<li>Adjusted EBITDA of $655 million to $675 million, from $660 million to $700 million</li>
<li>Free cash flow of $175 million to $195 million, from $160 million to $180 million</li>
</ul>

Guidance

AHCO

AdaptHealth Revises FY24 Net Revenue Outlook From $3.255B - $3.315B To $3.220B - $3.260B, (Est $3.276B)

Bioventus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 20 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $138.964 million which beat the analyst consensus estimate of $133.233 million by 4.30 percent. This is a 15.04 percent increase over sales of $120.794 million the same period last year.

Earnings

Earnings Beats

Bioventus Q3 2024 Adj. EPS $0.06 Beats $0.03 Estimate, Sales $138.964M Beat $133.233M Estimate

&#128201;The stock market declined last week,&nbsp;with the S&amp;P 500 shedding 1.4% to end at 5,728.80. The index is now up 20.1% year to date and up 60.2% from its October 12, 2022&nbsp;<a href="https://www.tker.co/p/bull-market-june-2023" rel="">closing low of 3,577.03</a>. For more on the stock market moves, read:&nbsp;<a href="https://www.tker.co/p/stock-market-drawdowns-bull-markets" rel="">Keep your stock market seat belts fastened</a>&nbsp;&#127906;
History shows that the stock market usually&nbsp;<a href="https://www.tker.co/p/us-presidents-stock-market-performance" rel="">performed well regardless</a>&nbsp;of the U.S. president&rsquo;s political party.
This suggests that there isn&rsquo;t a political party that&rsquo;s necessarily&nbsp;bad&nbsp;for the stock market.&nbsp;<a href="https://www.tker.co/p/us-presidents-stock-market-performance" rel="">Maybe some presidents are&nbsp;</a><a href="https://www.tker.co/p/us-presidents-stock-market-performance" rel="">better</a>&nbsp;for the market than others, especially at the industry level. But there isn&rsquo;t clear evidence showing that&nbsp;<a href="https://www.tker.co/p/us-presidents-stock-market-performance" rel="">a particular president&nbsp;</a><a href="https://www.tker.co/p/us-presidents-stock-market-performance" rel="">alone</a>&nbsp;can have enough of a material, long-term impact that the fundamentals driving the market higher will turn unfavorably.
&ldquo;Over time, the stock market&rsquo;s strongest threads have been the economy and earnings, not who&rsquo;s in the Oval Office,&rdquo; Ritholtz Wealth Management&rsquo;s Callie Cox&nbsp;<a href="https://x.com/callieabost/status/1851341245718647218" rel="">said</a>.
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcc771b18-b86d-40fc-9a06-d5815fed5beb_1456x833.jpeg" rel="" target="_blank"><img alt="" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fcc771b18-b86d-40fc-9a06-d5815fed5beb_1456x833.jpeg" style="height:357px; width:624px" /></a>
The stock market has a history of going up, regardless of the political party occupying the Oval Office. (Source:&nbsp;<a href="https://x.com/callieabost/status/1851341245718647218" rel="">@CallieCox</a>)
At the margin, however, the results of a presidential election can certainly cause market volatility to rise in the&nbsp;short-term. After all, each candidate comes with very different ideas for policies&nbsp;<a href="https://www.tker.co/p/corporate-tax-reform-vs-earnings-chart" rel="">like the corporate tax rate</a>. Over time, companies&nbsp;<a href="https://www.tker.co/p/earnings-growth-risks-question" rel="">will adapt and adjust</a>&nbsp;to new policies as they&nbsp;<a href="https://www.tker.co/p/corporate-tax-reform-vs-earnings-chart" rel="">work to preserve earnings growth</a>. But they need some clarity as to what those new policies could be before proceeding with changes.
As such, companies will often take a wait-and-see approach ahead of an uncertain election. That&rsquo;s a headwind for economic activity in the short-term. And with polling data showing the presidential candidates neck and neck ahead of this year&rsquo;s election, companies are once again saying that they&rsquo;ll wait for election results to move forward with any changed business strategies.
&ldquo;It was unsurprising that the U.S. election came up quite a bit in last week&rsquo;s earnings calls,&rdquo; RBC&rsquo;s Lori Calvasina said on Monday. &ldquo;As has been the case in recent quarters, there were numerous references to the uncertainty that the event has created and the adverse impact that uncertainty has had on business activity. Several companies noted the need to simply get to the other side.&rdquo;
Upgrade to paid
<h3>Declining Uncertainty Could Be Bullish Regardless Of The Election Outcome</h3>
Uncertainty doesn&rsquo;t only keep business executives on the sidelines. It keeps traders and investors on the sidelines too.
History shows that during election years, the stock market tends to deliver below-average returns ahead of Election Day. However, the rally tends to pick&nbsp;up once we &ldquo;get to the other side&rdquo; and the uncertainty wanes.
&ldquo;[R]egardless of the election outcome, declining uncertainty typically lifts equity valuations and prices following Election Day by more than the typical seasonality would suggest,&rdquo; Goldman Sachs&rsquo; Ben Snider&nbsp;<a href="https://www.tker.co/i/141606102/election-years-tend-be-good-but-less-good" rel="">wrote in a February note to clients</a>.
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0e4d5d18-150d-4b14-bd41-ef9962be9a7d_1564x1108.png" rel="" target="_blank"><img alt="" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F0e4d5d18-150d-4b14-bd41-ef9962be9a7d_1564x1108.png" style="height:442px; width:624px" /></a>
Stocks have historically performed weaker-than-average during election years ahead of Election Day, but strength generally returns after Election Day. (Source: Goldman Sachs via&nbsp;<a href="https://www.tker.co/i/141606102/election-years-tend-be-good-but-less-good" rel="">TKer</a>)
The fact that the S&amp;P 500 fell 1% in October is very much consistent with history.
&ldquo;October is the worst month of the year in an election year,&rdquo; Carson Group&rsquo;s Ryan Detrick said. &ldquo;So maybe down some last month shouldn&#39;t be a huge surprise?&rdquo;
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F478ac55d-d96f-4201-ba53-1e6a062b585f_1101x366.jpeg" rel="" target="_blank"><img alt="" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F478ac55d-d96f-4201-ba53-1e6a062b585f_1101x366.jpeg" style="height:207px; width:624px" /></a>
&nbsp;
(Source:&nbsp;<a href="https://x.com/RyanDetrick/status/1852350445194211420/" rel="">@RyanDetrick</a>)
&ldquo;What also shouldn&#39;t be a surprise is strength in November, as this is the best month of an election year,&rdquo; Detrick added.
Though, this election year has arguably been unusual in that year-to-date returns have been well above average. Through Friday, the S&amp;P 500 is up a little over 20%.
&ldquo;[These gains] would join 2021 (+22.61%), 2019 (+21.17%), and 2013 (+23.16%) as the only years in the 2000s with gains of over 20% up through this point of the year,&rdquo; Bespoke Investment Group observed on Thursday. &ldquo;Only looking at election years, however, this year&#39;s gain is the largest YTD rally in the S&amp;P 500 since 1936!&rdquo;
<a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9fd4ef2c-3ae2-4787-aadb-31767def0d1c_1166x620.jpeg" rel="" target="_blank"><img alt="" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9fd4ef2c-3ae2-4787-aadb-31767def0d1c_1166x620.jpeg" style="height:332px; width:624px" /></a>
This year is on track to be the best election year since 1936. (Source:&nbsp;<a href="https://x.com/bespokeinvest/status/1852049386840166617" rel="">@BespokeInvest</a>)
&ldquo;With equities having already posted huge returns this year, it raises the question of how performance looks for the rest of the year,&rdquo; Bespoke added. &ldquo;With only two prior examples of the S&amp;P 500 rallying 20% YTD headed into a presidential election, it isn&#39;t a big sample size so not too much weight should be put on it, but returns in November and from October through year&#39;s end have been mixed. Both times saw gains in November while the index was higher for the rest of the year in 1928 and slightly lower in 1936.&nbsp;The only other election year when the S&amp;P 500 was even up 15% YTD through the end of October (1980), November experienced a gain of 10.24% but the rest of the year&#39;s gain was just 6.5%.&rdquo;
Perhaps the market has gotten a little ahead of itself. Perhaps not. We&rsquo;ll only know what the rest of the year looks like until it&rsquo;s behind us.
<h3>Will We Know Who Won The Election Next Week?</h3>
Election Day is Tuesday. But experts warn we might not get final results by the end of the day.
&ldquo;With polls indicating another very tight race in 2024, many of the same factors that led to a delayed call in 2020 could be at play again,&rdquo; Goldman Sachs&rsquo; Michael Cahill said on Tuesday.
Upgrade to paid
But that doesn&rsquo;t mean the market won&rsquo;t have a better sense of what the next four years could look like.
&ldquo;While we cannot rule out the possibility of a very tight result and prolonged period of uncertainty, most likely the market will be able to gauge the likely presidential winner on election night or shortly thereafter, even if there are a few &lsquo;head fakes&rsquo; in the first few hours and media sources take longer to make their call &mdash; just like last time,&rdquo; Cahill said.
<h3>Zooming Out</h3>
You don&rsquo;t have to look very far back in history to see a president you didn&rsquo;t vote for or wouldn&rsquo;t have voted for occupy the Oval Office. And odds are, the&nbsp;<a href="https://www.tker.co/p/long-term-chart-us-stock-prices-since-1824" rel="">stock market performed pretty well</a>&nbsp;during his term.
To be clear, of course it&nbsp;matters&nbsp;who the president of the United States is: It has an immediate impact on sentiment, it could have short-term and long-term social implications, and it may even move the needle on the potential for economic growth.
But from a long-term investor&rsquo;s perspective, the president has an arguably marginal impact on the already existing forces driving the markets.
In the near-term, we should&nbsp;<a href="https://www.tker.co/p/stock-market-drawdowns-bull-markets" rel="">always brace for market volatility</a>. But getting past this election uncertainty &mdash; regardless of who wins &mdash; could prove to be a tailwind for markets.
&ldquo;Big picture, the reduction in uncertainty is almost always positive for asset prices, and we&rsquo;re at that moment of peak uncertainty,&rdquo; Ken Griffin, the billionaire founder of Citadel,&nbsp;<a href="https://www.bloomberg.com/news/articles/2024-10-29/citadel-s-ken-griffin-expects-trump-to-win-close-us-election" rel="">said on Tuesday</a>. &ldquo;Post election, we&#39;ll generally see a risk-on environment as people come to adopt a new regime, whether it&#39;s a Harris regime or a Trump regime. This uncertainty will be behind us.&rdquo;

Government

Markets

General

Getting To 'The Other Side' Of Election Uncertainty

Earnings Misses

Navios Maritime Partners Q3 2024 GAAP EPS $3.20 Misses $4.29 Estimate, Sales $340.800M Miss $377.047M Estimate

Susquehanna analyst Christopher Rolland maintains Cirrus Logic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRUS#NASDAQ">CRUS</a>) with a Positive and lowers the price target from $160 to $135.

CRUS

Susquehanna Maintains Positive on Cirrus Logic, Lowers Price Target to $135

WIIM

PAYO

Payoneer Global shares are trading higher after the company reported better-than-expected Q3 EPS and sales and raised its FY24 revenue guidance.

Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) is up 3.7% over the past 24 hours as positive news from its <a href="https://www.benzinga.com/money/shiba-inu-price-prediction">community bolster sentiment</a>.
What Happened: Pseudonymous lead developer Shytoshi Kusama <a href="https://blog.shib.io/strategic-hub-for-innovation-in-blockchain/">suggested</a> establishing a blockchain innovation hub in the U.S., inviting presidential candidates to endorse a "Silicon Valley" for the blockchain sector.  
This initiative, dubbed S.H.I.B., aims to drive economic growth, create quality jobs, and reinforce the U.S. as a leader in emerging technologies. Kusama estimated the project cost at $1.3 to $2.35 billion over 5-10 years.
By leveraging blockchain&#8217;s transformative potential, this S.H.I.B. initiative aims to stimulate economic growth, create high-quality jobs, enhance national security, and reinforce the United States&#8217; leadership in emerging technologies.
Crypto analyst Javon Marks reaffirmed his target price of $0.000081 for SHIB, suggesting the meme coin may be entering its next growth phase.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24SHIB&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$SHIB</a> (Shiba Inu) remains broken out and has confirmed a bull pattern with the RSI on the daily chart! Overall Target is still at $0.000081 and the next leg towards it can be in early stages, initiated by the falling wedge breakout&#8230; <a href="https://t.co/pbBS66quWM">https://t.co/pbBS66quWM</a> <a href="https://t.co/MVu7lBfoqG">pic.twitter.com/MVu7lBfoqG</a>
&mdash; JAVON&#x26a1;&#xFE0F;MARKS (@JavonTM1) <a href="https://twitter.com/JavonTM1/status/1853599365069472037?ref_src=twsrc%5Etfw">November 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Last week, trader Investing Haven noted that Shiba Inu "avoided" the forecasted drop in October thereby implying "strong buying interest and a breakout trend." He <a href="https://x.com/InvestingHaven/status/1852320937405989334">predicted</a> SHIB is "primed for a strong 2025."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41681345/dogecoin-killer-shiba-inu-burn-rate-explodes-254-078-higher-and-one-indicator-shows-a-90-r">&#8216;Dogecoin Killer&#8217; Shiba Inu Burn Rate Explodes 254,078% Higher And One Indicator Shows A 90% Rally Could Be Coming</a>
Why It Matters: Shibariumscan reported a rise in daily SHIB transactions from 4.68 million on Nov. 3 to 4.74 million on Nov. 4. Shibburn <a href="https://x.com/shibburn/status/1853633381621248439">data</a> shows the burn rate increasing by 5,929.2%. In the past 24 hours, 1.5 million SHIB coins were removed from the ecosystem.
Large transaction volume and daily active addresses declined by 6% and 10.7%, respectively, according to IntoTheBlock. Transactions greater than $100,000 are down from 147 to 114 in a single day.
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41616239/shytoshi-kusama-touts-shiba-inu-lifetime-gains-of-33774726-we-still-have-far-to-go-and-muc">Shytoshi Kusama Touts Shiba Inu Lifetime Gains Of 33774726%: &#8216;We Still Have Far To Go And Much Work To Be Done&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$SHIB

'Dogecoin Killer' Shiba Inu Up 3%: What Is Going On?

Scotiabank analyst George Farmer upgrades argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) from Sector Perform to Sector Outperform and raises the price target from $439 to $715.

Upgrades

ARGX

Scotiabank Upgrades argenx to Sector Outperform, Raises Price Target to $715

Cummins Q3 2024 Adj. EPS $5.60 Beats $4.80 Estimate

<figure class="table"> 
<table>
<tbody>
<tr>
<td>Previous FY 2024 Guidance</td>
<td>Updated FY 2024 Guidance</td>
</tr>
<tr>
<td>Net Sales</td>
<td>$1.44 to $1.48 billion</td>
</tr>
<tr>
<td>Adjusted EBITDA1</td>
<td>$240 to $250 million</td>
</tr>
<tr>
<td>Free Cash Flow1</td>
<td>$100 to $120 million</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;

HLMN

Hillman Solutions Revised Its 2024 Revenue Guidance To $1.455B-$1.485B (From $1.44B-$1.48B) Vs $1.467B Est.; Free Cash Flow To $100M-$115M (Vs. $100M-$120M Prior)

These monthly dividends, which will be payable pursuant to the table below, total $0.75 per share for the first quarter of 2025 and represent a 2.0% increase from the regular monthly dividends declared for the fourth quarter of 2024 and a 4.2% increase from the regular monthly dividends paid in the first quarter of 2024.

Dividends

MAIN

Main Street Declares Supplemental Dividend Of $0.30 Per Share Payable In December 2024; Boosts Regular Monthly Dividends To $0.25 Per Share For Each Of January, February And March 2025

CPI Card (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMTS#NASDAQ">PMTS</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.51 by 29.41 percent. This is a 100 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $124.75 million which beat the analyst consensus estimate of $117.13 million by 6.51 percent. This is a 17.84 percent increase over sales of $105.86 million the same period last year.

PMTS

CPI Card Q3 Adj $0.66 Beats $0.51 Estimate, Sales $124.75M Beat $117.13M Estimate

2024 Outlook:
Based on its current forecast, Cummins is maintaining its full-year 2024 revenue guidance to be in the range of down 3% to flat. EBITDA is expected to be approximately 15.5%; at the top end of the previous guidance of 15.0% to 15.5%.
Cummins plans to continue generating strong operating cash flow and returns for shareholders and is committed to our long-term strategic goal of returning 50% of operating cash flow back to shareholders. In the near term, we will focus on reinvesting for profitable growth, dividends and reducing debt.

Cummins Affirms FY24 Sales Guidance Of $33.04B-$34.06B Vs, $33.60B Estimate

2024 guidance is as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="2" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="2" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">$950 million - $960 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="2" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Transaction costs</td>
<td colspan="1" rowspan="1">~16.0% of revenue</td>
<td colspan="2" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Adjusted EBITDA (1)</td>
<td colspan="1" rowspan="1">$255 million to $265 million</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

Payoneer Global Sees FY24 Revenue $950M-$960M (Prior $920M-$930M) Vs $928.71M Est.; Transaction Costs ~16.0% Of Revenue (Prior ~16.5%); Adjusted EBITDA $255M-$265M (Prior $225M-$235M)

2024&nbsp;Financial Outlook
Based on its current operating plans, Karyopharm has further narrowed its guidance for full year 2024 as follows:
<ul>
<li>Total revenue to be in the range of $145.0 million to $155.0 million as compared to the Company's prior guidance of $145.0 million to $160.0 million. Total revenue consists of U.S. XPOVIO net product revenue and license, royalty and milestone revenue earned from partners.</li>
<li>U.S. XPOVIO net product revenue to be in the range of $110.0 million to $115.0 million as compared to the Company's prior guidance of $105.0 million to $120.0 million.</li>
<li>R&amp;D and selling, general and administrative (SG&amp;A) expenses to be in the range of $255.0 million to $265.0 million, which includes approximately $20.0 million estimated non-cash stock-based compensation expense, as compared to the Company's prior guidance of $250.0 million to $265.0 million.</li>
<li>The Company expects that its existing cash, cash equivalents and investments, the revenue it expects to generate from XPOVIO net product sales and its license agreements and ongoing disciplined expense management and cost saving measures, will be sufficient to fund its planned operations into the first quarter of 2026.</li>
</ul>

Biotech

Health Care

KPTI

Karyopharm Expects 2024 Sales Of $145M-$155M Versus Prior Guidance Of $145M-$160M And Consensus Of $152.352M

Baird analyst Tristan Gerra maintains Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) with a Outperform and lowers the price target from $7 to $5.

NVTS

Baird Maintains Outperform on Navitas Semiconductor, Lowers Price Target to $5

LGI Homes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGIH#NASDAQ">LGIH</a>) reported quarterly earnings of $2.95 per share which beat the analyst consensus estimate of $2.54 by 16.14 percent. The company reported quarterly sales of $651.854 million which beat the analyst consensus estimate of $646.459 million by 0.83 percent. This is a 5.56 percent increase over sales of $617.539 million the same period last year.

LGIH

LGI Homes Q3 2024 GAAP EPS $2.95 Beats $2.54 Estimate, Sales $651.854M Beat $646.459M Estimate

Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) is currently under investigation for potential tax fraud in France and the Netherlands. 
What Happened: The offices of the streaming giant were searched by investigators on Tuesday morning as part of a preliminary inquiry into alleged tax fraud and money laundering, reported Reuters.
The investigation, led by the French National Financial Prosecutor&#8217;s Office (PNF,) is focused on potential financial crimes and corruption. The probe, which began in November 2022, has led to searches at Netflix&#8217;s offices in central Paris and its European headquarters in Amsterdam.
A preliminary investigation in France does not automatically indicate that criminal charges will be filed or that a trial will occur.
See Also: <a href="https://www.benzinga.com/news/24/11/41703723/mark-cubans-million-dollar-advice-to-teens-if-i-were-16-again-id-start-this-lucrative-side-hustle?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Cuban&#8217;s Million-Dollar Advice To Teens: &#8216;If I Were 16 Again, I&#8217;d Start This Lucrative Side Hustle&#8217;</a>
Dutch authorities were simultaneously searching Netflix&#8217;s European headquarters in Amsterdam, according to the French judicial source. Neither Netflix France nor Netflix Netherlands have released a statement.
Netflix did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment.
Why It Matters: In 2022, Netflix settled a tax dispute with Italy by paying 55.8 million euros ($60.78 million). The company, which opened its Paris office in 2020, produces most of its original films and series by working with third-party contractors.
This investigation comes at a time of significant change within Netflix. The company recently <a href="https://www.benzinga.com/news/24/10/41631621/netflix-restructures-leadership-bids-farewell-to-two-key-executives">restructured its leadership</a>, with the departure of two key executives, Rachel Whetstone, chief communications officer, and Dean Garfield, VP of public policy. This restructuring was part of a planned change announced by Co-CEO Ted Sarandos.
Price Action: Netflix stock, which has gained 61.26% so far this year, was down 0.2% during premarket trading on Tuesday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41701405/dont-ever-use-this-word-around-mark-cuban-you-sound-stupid-because-youre-trying-to-sound-smart?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Don&#8217;t Ever Use This Word Around Mark Cuban: &#8216;You Sound Stupid &#8230; Because You&#8217;re Trying To Sound Smart&#8217;</a></li>
</ul>
This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Entertainment

Equities

Global

Tech

NFLX

Netflix In Hot Water As Tax Fraud Investigators Raid French, Dutch Offices: Report

CRGO

Freightos Welcomes Qantas Freight To WebCargo Platform, Enhancing Digital Booking Options Across Key Trans-Pacific Trade Routes

Singular Genomics announces 1-for-30 reverse stock split

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Singular Genomics Sys (NASDAQ:<a href="https://investorplace.com/stock-quotes/omic-stock-quote/">OMIC</a>) just reported results for the second quarter of 2023.<ul><li>Singular Genomics Sys reported earnings per share of -$10.50. This was above the analyst estimate for EPS of -$11.10.</li><li>The company reported revenue of $505,000.</li><li>This was 56.09% worse than the analyst estimate for revenue of $1.15 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/omic-stock-earnings-singular-genomics-sys-for-q2-of-2023/">OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023

Singular Genomics regains compliance with Nasdaq

Singular Genomics Systems GAAP EPS of -$8.57 beats by $0.29, revenue of $0.7M beats by $0.29M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Singular Genomics Sys (NASDAQ:<a href="https://investorplace.com/stock-quotes/omic-stock-quote/">OMIC</a>) just reported results for the second quarter of 2024.<ul><li>Singular Genomics Sys reported earnings per share of -$8.57. This was above the analyst estimate for EPS of -$8.88.</li><li>The company reported revenue of $737,000.</li><li>This was 84.25% better than the analyst estimate for revenue of $400,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/omic-stock-earnings-singular-genomics-sys-for-q2-of-2024/">OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q2 2024

Singular Genomics Systems, Inc. 2024 Q2 - Results - Earnings Call Presentation

Singular Genomics Systems, Inc. (OMIC) Q2 2024 Earnings Call Transcript

Singular Genomics receives acquisition proposal from Deerfield

Singular Genomics jumps after Tang's Concentra offers $12 a share

Deals this week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and more

AXNX

BATL

BLCO

BOOM

CACI

FLUT

INFN

MMSI

OMIC

PLTK

PYTCY

RVNC

SATS

SMAR

STZHF

VVPR

Press Releases

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results

Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024

Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

Singular Genomics Announces 1-for-30 Reverse Stock Split

Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024

Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results

Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital

Comments

Singular Genomics Sys

Intérêt court

Singular Genomics Sys (NASDAQ:OMIC) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL